Werfel Asked To Clarify How To Treat R&D Costs In M&A

By Law360 Staff · September 10, 2024, 3:27 PM EDT

Accounting firm RSM US LLP, in a letter released Tuesday, asked Internal Revenue Commissioner Daniel Werfel to clarify how to treat research and development costs when a taxpayer disposes of an...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login